142 related articles for article (PubMed ID: 33780252)
1. Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics.
Chen CJ; Chou CY; Shu KH; Chen HC; Wang MC; Chang CC; Hsu BG; Wu MS; Yang YL; Liao WL; Yang C; Hsiao YT; Huang CC
J Proteome Res; 2021 May; 20(5):2953-2963. PubMed ID: 33780252
[TBL] [Abstract][Full Text] [Related]
2. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
3. Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis.
Suh J; Han D; Ku JH; Kim HH; Kwak C; Jeong CW
Cancer Res Treat; 2022 Jul; 54(3):882-893. PubMed ID: 34645132
[TBL] [Abstract][Full Text] [Related]
4. Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
Xu N; Yao Z; Shang G; Ye D; Wang H; Zhang H; Qu Y; Xu F; Wang Y; Qin Z; Zhu J; Zhang F; Feng J; Tian S; Liu Y; Zhao J; Hou J; Guo J; Hou Y; Ding C
J Hematol Oncol; 2022 Jun; 15(1):76. PubMed ID: 35659036
[TBL] [Abstract][Full Text] [Related]
5. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
6. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.
Kamada M; Koshikawa N; Minegishi T; Kawada C; Karashima T; Shuin T; Seiki M
Cancer Sci; 2015 Dec; 106(12):1730-7. PubMed ID: 26450632
[TBL] [Abstract][Full Text] [Related]
7. Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.
Shimwell NJ; Bryan RT; Wei W; James ND; Cheng KK; Zeegers MP; Johnson PJ; Martin A; Ward DG
Br J Cancer; 2013 May; 108(9):1854-61. PubMed ID: 23591195
[TBL] [Abstract][Full Text] [Related]
8. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
[TBL] [Abstract][Full Text] [Related]
9. Urothelial cancer biomarkers for detection and surveillance.
Liou LS
Urology; 2006 Mar; 67(3 Suppl 1):25-33; discussion 33-4. PubMed ID: 16530072
[TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
Lotan Y; OʼSullivan P; Raman JD; Shariat SF; Kavalieris L; Frampton C; Guilford P; Luxmanan C; Suttie J; Crist H; Scherr D; Asroff S; Goldfischer E; Thill J; Darling D
Urol Oncol; 2017 Aug; 35(8):531.e15-531.e22. PubMed ID: 28366272
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.
Chen CL; Lin TS; Tsai CH; Wu CC; Chung T; Chien KY; Wu M; Chang YS; Yu JS; Chen YT
J Proteomics; 2013 Jun; 85():28-43. PubMed ID: 23631828
[TBL] [Abstract][Full Text] [Related]
12. Omics sciences and precision medicine in Urothelial Carcinoma.
Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
[TBL] [Abstract][Full Text] [Related]
13. Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.
Zhao Y; Li Y; Liu W; Xing S; Wang D; Chen J; Sun L; Mu J; Liu W; Xing B; Sun W; He F
J Proteomics; 2020 Aug; 225():103780. PubMed ID: 32298775
[TBL] [Abstract][Full Text] [Related]
14. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
[TBL] [Abstract][Full Text] [Related]
15. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
16. Current Use and Promise of Urinary Markers for Urothelial Cancer.
Tabayoyong W; Kamat AM
Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
[TBL] [Abstract][Full Text] [Related]
18. CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma.
Liu CL; Tsai HW; Peng SL; Chang CP; Chang YH; Huang HS
PLoS One; 2023; 18(3):e0281873. PubMed ID: 36862682
[TBL] [Abstract][Full Text] [Related]
19. Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources.
Tabaei S; Haghshenas MR; Webster TJ; Ghaderi A
Anal Biochem; 2023 Apr; 666():115074. PubMed ID: 36738874
[TBL] [Abstract][Full Text] [Related]
20. The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease.
Li AL; Chou CY; Chen CL; Wu KL; Lin SC; Chen HC; Wang MC; Chang CC; Hsu BG; Wu MS; Ma N; Huang CC
Front Med (Lausanne); 2021; 8():726214. PubMed ID: 34660637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
